Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DahLIA: Dexmedetomidine for ICU Agitation and Delirium
NCT01151865Phase 3Completed
- Sponsor
- Austin Health
- Start
- Feb 2011
- Primary completion
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of dexmedetomidine in delirium, psychomotor agitation, sponsored by Austin Health. Started Feb 2011; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
deliriumpsychomotor agitation
Beyond the preview
Go deeper on NCT01151865.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01151865.